Summary
Background:
Fractures in patients with hip or knee prostheses (periprosthetic fractures, PPF) are rare but clinically significant complications whose absolute number is steadily increasing as implantation rates rise. In Germany, approximately 200 000 hip and 170 000 knee joints are primarily replaced each year: PPFs account for approximately 15% of all revisions of hip surgery and 3% of all revisions of knee surgery.
Methods:
This review is based on publications retrieved by a selective search in the PubMed/MEDLINE and Google Scholar databases up to December 2025. Registry analyses, meta-analyses, systematic reviews, and clinical trials were included.
Results:
Key risk factors for PPF are advanced age (OR 1.4–1.7), female sex (OR 1.6–2.1), and osteoporosis as the overarching risk modifier. The 1-year mortality rate of 11-24% is comparable to that after fractures around the hip joint. History-taking and physical examination serve not only to assess fracture morphology but also to rule out implant loosening and low-grade infection. Most of the available evidence on treatment is derived from retrospective cohort and registry studies. The choice of treatment is mainly determined by implant stability: if the implant is stable, angle-stable osteosynthesis is performed; if it is loose, it must be replaced. The goal of surgery is a reconstruction that is stable under full weight-bearing, so that early functional mobilization can ensue and secondary complications can thereby be avoided.
Conclusion:
Interdisciplinary treatment planning for the early resumption of function, along with low-threshold osteoporosis screening in the presence of risk factors, are key strategies for lowering mortality and preventing further fractures.
Information on CME.
This article has been certified by the North Rhine Academy for Continuing Medical Education. The questions on this article may be found (in German) at http://daebl.de/RY95 (Deutsches Ärzteblatt’s CME portal). Their English translation may be found in the PDF version of this article. The closing date for entries is October 1, 2027.
Participation is possible at cme.aerzteblatt.de
Total hip and knee arthroplasty are among the most successful procedures in modern orthopedics. In Germany, approximately 200 000 primary hip and 170 000 primary knee arthroplasties are performed each year; the German Arthroplasty Registry recorded a total of about 410 000 hip and knee arthroplasty procedures in 2024, including follow-up and revision procedures (1). With increasing numbers of implantations, longer life expectancy, and rising activity levels among elderly patients, complications once regarded as uncommon are now receiving increasing attention. A particularly serious complication is a periprosthetic fracture (PPF—any fracture that occurs around an implanted endoprosthesis).
Despite their relative rarity, periprosthetic fractures account for approximately 15% of all revision hip arthroplasties and 3% of all revision knee arthroplasties in Germany (1, 2) and are associated with a one-year mortality rate comparable to that following a proximal femoral fracture (3, 4). These fractures are therefore among the complications with the poorest prognosis in joint replacement surgery. The present review provides a practical summary of the risk factors, clinical presentation and red flags, diagnostic approach, treatment principles, and key aspects of the postoperative management of periprosthetic fractures.
Methods
The review is based on publications retrieved by a selective search in the PubMed/MEDLINE and Google Scholar databases up to December 2025. The search was conducted using MeSH terms and free-text search terms related to periprosthetic fractures associated with hip and knee arthroplasty. Registry analyses, meta-analyses, systematic reviews, and clinical studies on classification, risk factors, and treatment were included. The evidence base is heterogeneous and comprises primarily retrospective cohort and registry studies; randomized controlled trials are unavailable for most of the treatment approaches.
Epidemiology and risk factors
Incidence and age distribution
The reviewed studies report cumulative incidence rates of periprosthetic fractures of 0.4–3.5% after hip arthroplasty (5, 6) and 0.3–2.5% after knee arthroplasty (7, 8), with follow-up periods ranging from two to 20 years. The median patient age was 75 to 80 years, and women accounted for 60% to 70% of cases (8, 9). Approximately 95% of periprosthetic fractures associated with knee prostheses involve the distal femur, 4% the proximal tibia, and the remainder the patella (8, 10). The median interval between primary implantation and fracture is two to seven years but may extend to two decades (9, 11). In a large Danish registry cohort of 120 642 primary knee arthroplasties, the cumulative 10-year incidence of periprosthetic fractures was 1.7% [1.6; 1.8] (7).
Risk factors
A recent meta-analysis of 36 studies identified the following independent risk factors for periprosthetic hip fractures: female sex (pooled odds ratio [OR] 1.60 [1.43; 1.78]), age over 70 years (OR 1.67 [1.19; 2.34]), obesity (OR 1.44 [1.01; 2.16]), rheumatoid arthritis (OR 1.89 [1.16; 3.06]), and a Deyo-Charlson Index score ≥3 (OR 1.44 [1.18; 1.77]) (12). The strongest modifiable implant-related risk factor is cementless fixation (OR 3.36 [3.02; 3.74]) (12). The Danish cohort study identified the following independent risk factors for periprosthetic fractures associated with knee prostheses: female sex (hazard ratio [HR] 2.1; 95% confidence interval [CI] [1.8; 2.4]), osteoporosis (HR 1.4 [1.2; 1.7]), age ≥80 years (HR 1.4 [1.3; 1.6]), cementless knee prosthesis (HR 1.3 [1.1; 1.5]), and a Charlson Comorbidity Index score ≥3 (HR 1.4 [1.1; 1.8]) (7). Pre-existing osteoporosis is regarded as an overarching risk modifier that amplifies the impact of other factors (13). It is noteworthy that an ipsilateral hip arthroplasty is an independent risk factor (HR 2.3), potentially indicating increased mechanical stress on the interprosthetic bone (7).
Mortality and morbidity
One-year mortality after periprosthetic hip fracture ranges from 11% to 24%, and two-year mortality ranges from 21% to 29%; these rates are comparable to those following proximal femoral fractures (3, 4, 14). Periprosthetic distal femoral fractures have a six-month mortality of 24% and a one-year mortality of 27% (15). Functional recovery also often remains incomplete: during the first year after a periprosthetic femoral fracture, the New Mobility Score decreases significantly (from a median of 7 to 5), the need for nursing-home care increases by around 16%, and a substantial proportion of patients do not regain their preinjury level of mobility (9, 14, 16).
Mechanism of injury
Load transmission at the bone-implant interface of an endoprosthesis follows different biomechanical principles than in native bone. Rigid stem implants cause periprosthetic osteopenia in the proximal bone (“stress shielding”), with subsequent bone remodeling and loss of cortical strength, while mechanical stress concentrations—areas exposed to increased bending moments—shift to the stem tip and the periprosthetic transition zones (17, 18). These transition zones are predisposed to fracture. In addition, most patients are over 70 years old and already have clinically relevant osteoporosis with reduced bone stability (19). Low-energy trauma, such as a fall from standing height, may be sufficient to cause a fracture; occasionally, a fracture may even occur spontaneously, without a recalled event. Cementless press-fit anchoring (tight-fitting implantation without bone cement) is associated with a higher risk of intraoperative and early postoperative fractures due to the high initial stress on the surrounding bone, especially in patients with osteoporotic bone (19, 20).
Clinical presentation and red flags
Acute fracture
The typical history of a periprosthetic fracture is a minor injury – such as a domestic fall, a fall from standing height, a trip, or a misstep, although a significant proportion of patients cannot recall any adequate injury (a so-called spontaneous fracture) (9, 11). Key clinical symptoms include sudden pain on weight-bearing, loss of function, and—in the case of displaced fractures—visible axial malalignment, leg shortening, or external rotation deformity.
Signs of pre-existing implant loosening
A clinically relevant proportion of periprosthetic fractures occur in the setting of implant loosening that was already present before the injury. Clinical signs include new-onset or worsening start-up and weight-bearing pain over weeks to months, progressive leg shortening, audible crepitus or grinding during movement, and gradual loss of function without a traumatic event (21, 22). Persistent symptoms since the primary implantation or new-onset pain after an initial symptom-free interval are particularly suspicious.
Signs of infection
The heading “Signs of infection” encompasses clinical findings and features of the patient’s history suggestive of a periprosthetic joint infection. Such infection often precedes implant loosening and may therefore increase the risk of fracture. These include persistent pain since implantation, fever during the early postoperative period, a history of impaired wound healing or wound drainage, recurrent cellulitis of the affected leg, sinus tract formation, and new-onset pain at rest (23). Persistently elevated inflammatory markers (C-reactive protein and white blood cell count) without another identifiable cause reinforce the suspicion.
Examination findings
Weight-bearing pain, pain with axial loading and compression, limited range of motion, leg-length discrepancy, and neurovascular status should be systematically documented during the physical examination. A low threshold should be maintained for obtaining radiographs in two projections whenever there is clinical suspicion of a periprosthetic fracture. The Table presents an overview of the key clinical presentations and the diagnostic workup indicated in each case.
Table. Clinical presentations with typical symptoms and recommended actions in cases of suspected periprosthetic fracture.
| Clinical presentation* | Typical symptoms and findings from the patient’s history | Red flag and recommended action |
|---|---|---|
| Acute traumatic periprosthetic fracture | Sudden pain on weight-bearing after a fall or minor injury; loss of function; visible axial malalignment, leg shortening, or external rotation; hematoma possible but not obligatory | Immediate hospital admission; radiographs in two projections, including the prosthesis and adjacent joints; no weight-bearing on the affected limb |
| Spontaneous fracture without adequate trauma | Pain on weight-bearing and loss of function with no recollection of any triggering event; often insidious onset; more common in patients with osteoporosis, long-term glucocorticoid therapy, or an underlying neurological disease | Low-threshold for radiological investigation; if radiography unremarkable and pain persistent, CT to exclude occult fracture; referral to specialized arthroplasty center |
| Suspected implant loosening | Pain after inactivity, new-onset or progressive weight-bearing pain over weeks or months; progressive leg shortening; audible crepitus or grinding sounds; insidious loss of function with no traumatic event | X-ray with comparison with previous images (radiolucent lines, implant migration); timely specialist evaluation at a specialized arthroplasty center |
| Suspected low-grade periprosthetic infection | Persistent pain since primary implantation; new-onset pain after symptom-free interval; history of impaired wound healing or wound drainage; recurrent cellulitis; persistently elevated inflammatory markers without any other identifiable cause | Measurement of CRP and white blood cell count; referral for joint aspiration before any antibiotic therapy; no empiric antibiotic therapy without obtaining microbiological specimens |
| Acute periprosthetic infection | Fever, chills; local erythema, swelling, increased warmth; secretion or sinus tract; acute-onset pain at rest; markedly elevated inflammatory markers | Immediate admission to hospital; no antibiotics before obtaining microbiological specimens; surgical debridement with specimen collection for pathogen identification |
The presentations listed are not mutually exclusive and may overlap – in particular, a periprosthetic fracture may be the manifestation of a pre-existing loosening or a l ow-grade infection. CRP, C-reactive protein; CT, computed tomography
Diagnostic investigations
A structured diagnostic assessment comprises the patient’s history, physical examination, and diagnostic imaging. History taking should include documentation of the mechanism of injury, symptoms preceding the fracture, previous operations, implant details, and potential signs of infection (Table). Persistent pain or loss of function prior to the fracture may indicate pre-existing implant loosening or a low-grade infection and must be specifically explored during history taking. For the knee, functional assessment of the extensor mechanism is also a mandatory component of the physical examination.
In terms of imaging, plain radiographs in two projections are essential and should provide complete visualization of the implant, the fracture, and the adjacent joints. Comparison with previous radiographs is diagnostically important: progressive radiolucent lines, implant migration, or fracturing of the cement mantle indicate pre-existing loosening. Computed tomography with metal artifact reduction is indicated for complex fractures, uncertain implant stability, or preoperative planning. However, implant stability can often be definitively assessed only during surgery. Therefore, if implant stability remains uncertain, it should be assessed intraoperatively by standardized stability testing of the prosthetic component during fracture surgery.
If the clinical presentation or the patient’s history raises suspicion of a periprosthetic infection, an extended infection workup is mandatory: measurement of C-reactive protein and the white blood cell count, followed by joint aspiration with synovial fluid analysis (white blood cell count, differential, and microbiological culture). Samples must be collected before any antibiotic therapy is initiated, as empiric antibiotic treatment can substantially hinder or even prevent pathogen identification.
Classification and treatment principles
Classification concept
All commonly used classification systems for periprosthetic fractures are based on the same fundamental principle: assessment of fracture location, implant stability, and bone quality. The Vancouver classification (24) is widely used internationally for periprosthetic femoral fractures associated with hip arthroplasty. It distinguishes between trochanteric fractures (type A), fractures at the level of the stem (type B; subtype B1: stable stem; B2: loose stem with good bone stock; B3: loose stem with compromised bone stock), and fractures distal to the stem (type C). The joint-specific classification systems for the distal femur (Lewis-Rorabeck) (25), proximal tibia (Felix) (26), patella (Ortiguera and Berry) (27), and acetabulum (Pascarella) (28), together with the overarching Unified Classification System (UCS) (29), are summarized in the eTable.
eTable. Overview of the most commonly used classification systems for periprosthetic fractures of the hip and knee*.
| Classification (Ref) | Location | Classification criteria | Types/categories | Therapeutic implications |
|---|---|---|---|---|
| Vancouver
Classification (24) |
Femur (hip prosthesis) | Fracture location relative to the stem, implant stability, bone quality | A: trochanteric region (AG: greater trochanter; AL: lesser trochanter); B: at the level of the stem (B1: stable stem; B2: loose stem, good bone stock; B3: loose stem, poor bone stock); C: distal to the stem | International standard; the choice between internal fixation (B1, C) and revision arthroplasty (B2, B3) is based primarily on stem stability |
| Peterson-Lewallen
Classification (30) |
Acetabulum (hip prosthesis) | Acetabular cup stability | Type 1: stable cup; Type 2: unstable/ loosened cup | Simple dichotomy: type 1 often nonoperative or plate fixation; type 2 requires acetabular revision |
| Pascarella
Classification (28) |
Acetabulum (hip prosthesis) | Timing of fracture (intraoperative vs. postoperative), fracture morphology, acetabular cup stability | Multi-tiered classification with subtypes for intraoperative fractures during press-fit cup insertion, postoperative traumatic and stress-related fractures | Allows the formulation of differentiated treatment algorithms; also takes pelvic discontinuity into account |
| Lewis-Rorabeck
Classification (25) |
Distal femur (knee prosthesis) | Fracture displacement, implant stability | Type I: nondisplaced, implant stable;
Type II: displaced, implant stable; Type III: displaced, implant loose |
Widely used in clinical practice. type III requires revision arthroplasty (with distal femoral replacement where appropriate); types I and II are amenable to internal fixation |
| Su Classification (31) | Distal femur (knee prosthesis) | Location of the fracture line in relation to the femoral component | Type I: proximal to the anterior flange;
Type II: originating at the level of the anterior flange; Type III: distal to the anterior flange |
Supplementary to the Lewis-Rorabeck classification; clinically relevant when choosing between plate fixation and retrograde intramedullary nailing |
| Felix Classification (26) | Proximal tibia (knee prosthesis) | Anatomical location; status of tibial implant component (stable vs. loose) indicated by an additional letter | Type I: tibial plateau; Type II: adjacent to the tibial stem; Type III: distal to the prosthesis; Type IV: involves the tibial tubercle | Standard classification for tibial fractures. Implant stability determines choice between internal fixation and revision; type IV fractures require stabilization of the extensor mechanism |
| Ortiguera and Berry Classification (27) | Patella (knee prosthesis) | Stability of the patellar implant, integrity of the extensor mechanism | Type I: stable patellar implant, intact extensor mechanism; Type II: disrupted extensor mechanism; Type IIIa: loose patellar implant, good patellar bone stock; Type IIIb: loose patellar implant, poor patellar bone stock | Treatment ranges from nonoperative management (type I) to extensor mechanism reconstruction (type II) and component exchange (type III) |
| Keating
Classification (32) |
Patella (knee prosthesis) | Fracture morphology, component stability, extensor mechanism function | Type A: nondisplaced, stable; Type B: displaced, intact extensor mechanism; Type C: displaced, disrupted extensor mechanism | An alternative to the Ortiguera and Berry classification, with similar treatment implications |
| Unified Classification System UCS (29) | Applicable across different joints | Unified regimen comprising six types (A-F) based on fracture location, implant stability, bone stock, timing of the fracture | A: Apophyseal; B: Bed of implant; C: Clear of implant; D: Dividing the bone between two implants (interprosthetic fracture); E: Each of the two bones supporting a joint replacement; F: Facing and articulating with a hemiarthroplasty | Conceptual framework incorporating joint-specific classifications; in clinical routine practice, clinicians continue to rely primarily on the respective established classification systems |
All systems are based on the fundamental principle of incorporating fracture location, implant stability, and bone quality as variables to guide treatment. In clinical routine practice, clinicians rely primarily on joint-specific classification systems.
vs., versus
Treatment principles
The management of periprosthetic fractures is governed by a fundamental principle: treatment is primarily determined by implant stability. If the component is stable, implant-preserving treatment involving anatomical fracture reduction and stable fixation is the primary approach. If loosening is confirmed, component exchange with a revision implant is indicated, combined with reconstruction of the bone defect where necessary. The application of this principle is outlined below for periprosthetic proximal femoral fractures based on the established Vancouver classification (eTable).
Nonoperative treatment
Nonoperative treatment should be considered only for nondisplaced fractures with a stable implant component or in patients at prohibitive surgical risk. It involves temporary partial weight-bearing, early functional mobilization, and close radiographic follow-up to detect secondary displacement or implant loosening at an early stage. Prolonged immobilization should be avoided in this generally multimorbid patient population because of the high risk of complications.
Vancouver A—Trochanteric fractures
Avulsion fractures of the greater or lesser trochanter often result from a direct fall or occur as an intraoperative complication during implant insertion. Nondisplaced fractures are managed non-operatively with modified weight-bearing. Displaced greater trochanteric fractures that impair function require reattachment of the fragment using cerclage wires or a hook plate to restore the gluteal insertion.
Vancouver B—Fractures around or just below the stem
These are the most common and clinically significant types of periprosthetic fracture. Vancouver B1 fractures with a stable femoral stem are managed with locking plate fixation, commonly supplemented by proximal cerclage wires, while preserving the original implant. Vancouver B2 fractures with a loose stem generally require a long, usually cementless, revision stem that bridges the fracture zone and ensures load transfer distal to the fracture; additional stabilization of the fracture with cerclage wires may be necessary. For selected cemented stems, implant-preserving open reduction and internal fixation (ORIF) is increasingly being considered as an alternative to revision. A recent meta-analysis found no significant difference between ORIF and revision in five-year implant survival (OR 0.64 [0.26; 1.60]) or one-year mortality (OR 2.05 [0.71; 5.89]); the two-year reoperation rate, however, was significantly lower after ORIF (OR 0.28 [0.14; 0.53]) (33). Vancouver B3 fractures—by definition associated with a loose stem and major bone loss with cortical thinning or extensive osteolysis – require a combination of a revision stem and biological or mechanical augmentation, such as cortical strut allografts. If reconstruction is not feasible, proximal femoral replacement may be used as a salvage procedure (18). Distinguishing between B1 and B2 fractures is clinically and radiographically challenging and is often possible only through intraoperative stability testing (34); B3 fractures, by contrast, are usually diagnosed before surgery. The surgical management of periprosthetic proximal femoral fractures is illustrated in Figure 1.
Figure 1:

Surgical management of a periprosthetic proximal femoral fracture following total hip replacement with a cemented stem (Vancouver B3)
a) Preoperative X-rays: fracture line in the stem region extending through the cement mantle;
b) and c) Routine postoperative radiographs following revision surgery with additional cerclage wires
Vancouver C—Fractures distal to the tip of the stem.
Fractures distal to the tip of the stem with a stable femoral component are managed as conventional distal femoral fractures, using locking plate fixation or retrograde intramedullary nailing. Adequate overlap between the plate and the stem tip is crucial, as unprotected cortical segments between the implant and the plate increase the risk of subsequent fractures.
The management principles described for the proximal femur can also be applied to the other anatomical locations: the treatment strategy for the distal femur (locking plate fixation or a retrograde intramedullary nailing if the implant is stable; distal femoral replacement in cases of major loosening), the proximal tibia, and the patella (extensor mechanism stabilization) is also determined by implant stability, fracture morphology, and bone stock. Treatment should be provided by an interdisciplinary team at a specialized arthroplasty center; the general treatment algorithm for periprosthetic fractures is summarized in Figure 2.
Figure 2. Diagnostic and treatment algorithm for periprosthetic fractures of the hip and knee.

If infection is suspected based on clinical findings or the patient’s history, further diagnostic evaluation, including joint aspiration before administration of antibiotics, is mandatory. Once an infection has been ruled out, implant stability is assessed. Implant stability can often be definitively assessed only during surgery. Therefore, if uncertainty remains, definitive assessment during surgical fracture treatment is recommended. Nonoperative treatment may be considered in patients with a prohibitive surgical risk and a nondisplaced fracture with a stable component. Treatment should be provided by an interdisciplinary team at a specialized arthroplasty center.
CRP, C-reactive protein; CT, computed tomography; DFR, distal femoral replacement; DVO, Umbrella Association of German-Speaking Scientific Societies for Osteology;
PFR, proximal femoral replacement; PJI, prosthetic joint infection
Timing of surgery
Surgical treatment within 24 to 48 hours should be the goal, provided the patient’s general condition allows this; medically justified delays to optimize comorbidities or coagulation status must be weighed against the risk of prolonged immobilization.
Postoperative management and long-term course
Mobilization
Timely surgical treatment aimed at achieving a construct that permits postoperative weight-bearing is a prerequisite for adequate early functional mobilization, which is one of the most important determinants of clinical outcome. Randomized data specifically examining early mobilization after periprosthetic fractures are not available; however, evidence from the well-studied analogous setting of proximal femoral fractures demonstrates that failure to mobilize within 10 days, regardless of surgical timing, is associated with an almost twofold increase in one-year mortality (17% vs. 7%; p <0.01) (35). Provided the fracture fixation allows, the objective should be full postoperative weight-bearing, as older patients are often unable to adhere to non-weight-bearing or partial weight-bearing restrictions. The weight-bearing regime should be determined on an individual basis by the interdisciplinary treatment team.
In very elderly patients with multiple comorbidities, the indication for surgical treatment should be carefully weighed on a case-by-case basis, balancing potential improvements in mobility against perioperative risks. A purely palliative approach may be justified in exceptional cases, for example, in moribund patients or when there is no realistic prospect of mobilization. The decision should be reached in consultation with patients and family members, with input from geriatric specialists.
Osteoporosis and secondary prevention
Every periprosthetic fracture should be regarded as equivalent to a fragility fracture and, as such, is associated with an increased risk of further fractures. Low-threshold osteoporosis screening, including bone density measurement (DXA) and assessment of vitamin D status, should be initiated in patients with typical risk factors, such as advanced age, female sex, long-term glucocorticoid therapy, a history of fragility fractures, or rheumatoid arthritis. The indication for specific pharmacotherapy should be determined according to the guideline issued by the Umbrella Association of German-Speaking Scientific Societies for Osteology (DVO) (36). In addition, adequate supplementation with vitamin D (at least 800 IU/day) and calcium (1000 mg/ day via diet or supplements) is recommended.
Care coordination and lifestyle recommendations
The specialized arthroplasty center is responsible for acute surgical management; clinical and radiographic follow-up visits are usually scheduled at the center six weeks, three months, and 12 months after surgery. Once fracture healing is confirmed, further follow-up care can be transferred to the patient’s primary care physician. Referral back to the arthroplasty center is indicated in patients with progressive pain, new-onset functional impairment, or signs of a periprosthetic infection. Lifestyle recommendations include fall prevention (home environment modifications, appropriate footwear, and assistive devices), avoiding high-impact sports in favor of low-impact, joint-friendly activities (swimming, cycling, and walking), and maintaining a balanced diet with adequate protein and micronutrient intake. These secondary preventive measures are an interdisciplinary challenge of considerable prognostic significance.
Future perspectives and limitations
Periprosthetic fractures will become increasingly important as joint arthroplasty volumes grow and life expectancy continues to rise. The identification of high-risk patients prior to primary arthroplasty, structured care by the interdisciplinary team, and consistent secondary prevention remain key challenges. Before elective procedures, the focus is increasingly on prehabilitation – the targeted preoperative optimization of nutritional status, muscle strength, comorbidities, and mobility – as this can improve functional outcomes, particularly in older patients (Box). AI-assisted image analysis may, in the future, support the identification of early signs of loosening and subtle fracture patterns but is not yet part of standard clinical practice. For major bone defects, patient-specific implants produced using 3D printing are becoming increasingly important, especially for acetabular reconstruction and customized femoral replacement constructs. Evidence regarding treatment strategies is based predominantly on retrospective cohort and registry studies; randomized trials are particularly needed to compare fracture fixation with component exchange. The first prospective multicenter trials have been initiated; their findings will shape the treatment algorithms of the coming years.
Box. Clinical implications.
-
Frequency and trend
Fractures associated with a hip or knee prosthesis are rare complications, but their absolute numbers are increasing. They are responsible for approximately 15% of all hip revision procedures and 3% of all knee revision procedures in Germany and typically affect older patients with multiple comorbidities.
-
Red flags and clinical presentation
Key indicators include sudden pain on weight-bearing, loss of function, or unexplained symptoms following minor trauma. Persistent pain or functional limitations present before the fracture occurred may indicate implant loosening or a low-grade infection and must be actively investigated.
-
Diagnostic investigations
Standard diagnostic investigations include plain radiographs in two projections, compared with previous images: if a periprosthetic infection is suspected based on clinical findings or the patient’s history, further diagnostic evaluation, including joint aspiration and measurement of inflammatory markers, is required.
-
Treatment principle based on implant stability
The operative strategy is determined by implant stability: if the implant is securely fixed, locking plate fixation is performed; if it is loose, the component is exchanged. The one-year mortality rate of 11-24% is comparable to that following proximal femoral fractures and warrants timely surgical treatment aimed at early functional mobilization.
-
Secondary prevention
Every periprosthetic fracture should be considered equivalent to a fragility fracture. Osteoporosis evaluation and, if indicated, specific pharmacotherapy should be initiated with a low threshold in patients with risk factors to reduce the risk of re-fracture.
Footnotes
Conflict of interest statement: The authors declare that no conflict of interest exists.
Supplementary material
Complete list of full references
- 1.EPRD Deutsche Endoprothesenregister gGmbH . EPRD gGmbH. Berlin: 2025. Endoprothesenregister Deutschland (EPRD): Jahresbericht 2025 — Berichtsjahr 2024. [Google Scholar]
- 2. Meek RMD, Norwood T, Smith R, Brenkel IJ, Howie CR. The risk of peri-prosthetic fracture after primary and revision total hip and knee replacement. J Bone Joint Surg Br. 2011;93:96–101. doi: 10.1302/0301-620X.93B1.25087. [DOI] [PubMed] [Google Scholar]
- 3. Bhattacharyya T, Chang D, Meigs JB, Estok DM, 2nd, Malchau H. Mortality after periprosthetic fracture of the femur. J Bone Joint Surg Am. 2007;89:2658–62. doi: 10.2106/JBJS.F.01538. [DOI] [PubMed] [Google Scholar]
- 4. Lamb JN, Nix O, Al-Wizni A, West R, Pandit H. Mortality after postoperative periprosthetic fracture of the femur after hip arthroplasty in the last decade: Meta-analysis of 35 cohort studies including 4841 patients. J Arthroplasty. 2022;37:398-405.e1. doi: 10.1016/j.arth.2021.09.006. [DOI] [PubMed] [Google Scholar]
- 5. Thien TM, Chatziagorou G, Garellick G, et al. Periprosthetic femoral fracture within two years after total hip replacement: Analysis of 437,629 operations in the Nordic Arthroplasty Register Association database. J Bone Joint Surg Am. 2014;96:e167. doi: 10.2106/JBJS.M.00643. [DOI] [PubMed] [Google Scholar]
- 6. Sidler-Maier CC, Waddell JP. Incidence and predisposing factors of periprosthetic proximal femoral fractures: A literature review. Int Orthop. 2015;39:1673–82. doi: 10.1007/s00264-015-2721-y. [DOI] [PubMed] [Google Scholar]
- 7. Risager SK, Arndt KB, Abrahamsen C, Viberg B, Odgaard A, Lindberg-Larsen M. Risk and epidemiology of periprosthetic knee fractures after primary total knee arthroplasty: A nationwide cohort study. J Arthroplasty. 2024;39:2615–20. doi: 10.1016/j.arth.2024.05.033. [DOI] [PubMed] [Google Scholar]
- 8. Frosch KH, Madert J. Kniegelenksnahe Frakturen bei Knie-TEP. OPJournal. 2015;31:37–44. [Google Scholar]
- 9. Lindahl H, Malchau H, Herberts P, Garellick G. Periprosthetic femoral fractures: Classification and demographics of 1049 periprosthetic femoral fractures from the Swedish National Hip Arthroplasty Register. J Arthroplasty. 2005;20:857–65. doi: 10.1016/j.arth.2005.02.001. [DOI] [PubMed] [Google Scholar]
- 10. Ruchholtz S, Tomás J, Gebhard F, Larsen MS. Periprosthetic fractures around the knee—the best way of treatment. Eur Orthop Traumatol. 2013;4:93–102. doi: 10.1007/s12570-012-0130-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Abdel MP, Watts CD, Houdek MT, Lewallen DG, Berry DJ. Epidemiology of periprosthetic fracture of the femur in 32 644 primary total hip arthroplasties: A 40-year experience. Bone Joint J. 2016;98-B:461–7. doi: 10.1302/0301-620X.98B4.37201. [DOI] [PubMed] [Google Scholar]
- 12. Zhao WQ, Yu KQ, Xie RZ, Liang YF, Huang JF. Risk factors for periprosthetic femoral fractures following hip arthroplasty: A systematic review and meta-analysis. Ann Med. 2025;57:2494679. doi: 10.1080/07853890.2025.2494679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Houel V, Marchasson G, Ramdane N, et al. Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis. Osteoporos Int. 2025;36:1061–8. doi: 10.1007/s00198-025-07486-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. COMPOSE Study Team: Management and outcomes of femoral periprosthetic fractures at the hip: Data from the characteristics, outcomes and management of periprosthetic fracture service evaluation (COMPOSE) cohort study. Bone Joint J. 2022;104-B:997–1008. doi: 10.1302/0301-620X.104B8.BJJ-2021-1682.R1. [DOI] [PubMed] [Google Scholar]
- 15. Streubel PN, Ricci WM, Wong A, Gardner MJ. Mortality after distal femur fractures in elderly patients. Clin Orthop Relat Res. 2011;469:1188–96. doi: 10.1007/s11999-010-1530-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Stanley R, Roodt R, Umar M, et al. Impact of periprosthetic femoral fractures on frailty, mobility and outcomes in hip arthroplasty. J Orthop Surg Res. 2025;20:967. doi: 10.1186/s13018-025-06446-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Masri BA, Meek RMD, Duncan CP. Periprosthetic fractures evaluation and treatment. Clin Orthop Relat Res. 2004;420:80–95. doi: 10.1097/00003086-200403000-00012. [DOI] [PubMed] [Google Scholar]
- 18. Stoffel K, Horn T, Zagra L, Mueller M, Perka C, Eckardt H. Periprosthetic fractures of the proximal femur: Beyond the Vancouver classification. EFORT Open Rev. 2020;5:449–56. doi: 10.1302/2058-5241.5.190086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Bauer J, Duero J, Lindsay A. The role of osteoporosis in total hip arthroplasty periprosthetic fractures and current management strategies: A review. Curr Osteoporos Rep. 2025;23:29. doi: 10.1007/s11914-025-00922-5. [DOI] [PubMed] [Google Scholar]
- 20. Lindberg-Larsen M, Petersen MM, Husted H, et al. Periprosthetic femoral fractures after cementless versus cemented total hip arthroplasty: A registry-based study. Acta Orthop. 2017;88:390–4. [Google Scholar]
- 21. Gruner A, Hockertz T, Reilmann H. Die periprothetische Fraktur. Klassifikation, Management, Therapie. Unfallchirurg. 2004;107:35–49. doi: 10.1007/s00113-003-0698-2. [DOI] [PubMed] [Google Scholar]
- 22. Ramavath A, Lamb JN, Palan J, Pandit HG, Jain S. Postoperative periprosthetic femoral fracture around total hip replacements: Current concepts and clinical outcomes. EFORT Open Rev. 2020;5:558–67. doi: 10.1302/2058-5241.5.200003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Parvizi J, Tan TL, Goswami K, et al. The 2018 definition of periprosthetic hip and knee infection: An evidence-based and validated criteria. J Arthroplasty. 2018;33:1309–14. doi: 10.1016/j.arth.2018.02.078. [DOI] [PubMed] [Google Scholar]
- 24. Duncan CP, Masri BA. Fractures of the femur after hip replacement. Instr Course Lect. 1995;44:293–304. [PubMed] [Google Scholar]
- 25. Rorabeck CH, Taylor JW. Classification of periprosthetic fractures complicating total knee arthroplasty. Orthop Clin North Am. 1999;30:209–14. doi: 10.1016/s0030-5898(05)70075-4. [DOI] [PubMed] [Google Scholar]
- 26. Felix NA, Stuart MJ, Hanssen AD. Periprosthetic fractures of the tibia associated with total knee arthroplasty. Clin Orthop Relat Res. 1997;345:113–24. [PubMed] [Google Scholar]
- 27. Ortiguera CJ, Berry DJ. Patellar fracture after total knee arthroplasty. J Bone Joint Surg Am. 2002;84:532–40. doi: 10.2106/00004623-200204000-00004. [DOI] [PubMed] [Google Scholar]
- 28. Pascarella R, Sangiovanni P, Cerbasi S, et al. Periprosthetic acetabular fractures: A new classification proposal. Injury. 2018;49(Suppl 3):S65–S73. doi: 10.1016/j.injury.2018.09.061. [DOI] [PubMed] [Google Scholar]
- 29. Duncan CP, Haddad FS. The unified classification system (UCS): Improving our understanding of periprosthetic fractures. Bone Joint J. 2014;96-B:713–6. doi: 10.1302/0301-620X.96B6.34040. [DOI] [PubMed] [Google Scholar]
- 30. Peterson CA, Lewallen DG. Periprosthetic fracture of the acetabulum after total hip arthroplasty. J Bone Joint Surg Am. 1996;78:1206–13. doi: 10.2106/00004623-199608000-00011. [DOI] [PubMed] [Google Scholar]
- 31. Su ET, DeWal H, Di Cesare PE. Periprosthetic femoral fractures above total knee replacements. J Am Acad Orthop Surg. 2004;12:12–20. doi: 10.5435/00124635-200401000-00003. [DOI] [PubMed] [Google Scholar]
- 32. Keating EM, Haas G, Meding JB. Patella fracture after post total knee replacements. Clin Orthop Relat Res. 2003;416:93–7. doi: 10.1097/01.blo.0000092992.90435.20. [DOI] [PubMed] [Google Scholar]
- 33. Choudhary Z, Singal S, Selim A, et al. Fixation vs. revision of Vancouver B2 periprosthetic fractures around polished tapered cemented femoral stems: A meta-analysis of outcomes. JBJS Rev. 2025;13:12. doi: 10.2106/JBJS.RVW.25.00215. [DOI] [PubMed] [Google Scholar]
- 34. Maggs JL, Swanton E, Whitehouse SL, et al. B2 or not B2? That is the question: A review of periprosthetic fractures around cemented taper-slip femoral components. Bone Joint J. 2021;103-B:71–8. doi: 10.1302/0301-620X.103B1.BJJ-2020-0163.R1. [DOI] [PubMed] [Google Scholar]
- 35. Aprato A, Bechis M, Buzzone M, Bistolfi A, Daghino W, Massè A. No rest for elderly femur fracture patients: Early surgery and early ambulation decrease mortality. J Orthop Traumatol. 2020;21:12. doi: 10.1186/s10195-020-00550-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Dachverband Osteologie e.V. (DVO): DVO-Leitlinie 2023 zur Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei Männern. Stuttgart: Dachverband Osteologie. 2023.
Questions on the article in issue 20/2026: Fractures in Patients with Hip and Knee Prostheses
The submission deadline is 1 October 2027. Only one answer is possible per question.
Please select the answer that is most appropriate.
-
Question 1
Approximately how many primary hip arthroplasties are performed in Germany each year?- approx. 20 000;
- approx. 50 000;
- approx.100 000;
- approx. 150 000;
- approx. 200 000
-
Question 2
Which of the following factors is cited in the article as the strongest modifiable implant-related risk factor for periprosthetic hip fractures?- the use of titanium prostheses
- the use of zirconia prostheses
- cementless fixation
- screwless fixation
- fixation without intramedullary nailing
-
Question 3
What percentage of hip and knee revision procedures in Germany are attributable to periprosthetic fractures?- 28% and 10%, respectively;
- 15% and 3%, respectively;
- 10% and 0%, respectively;
- 5% and 13%, respectively;
- 2% and 25%, respectively
-
Question 4
Which statement regarding mortality or morbidity following a periprosthetic hip fracture is most accurate?- A periprosthetic hip fracture does not usually increase the need for nursing home care.
- Mortality is substantially higher than that after a proximal femoral fracture.
- Mortality is comparable to that after a proximal femoral fracture.
- All patients regain their pre-injury level of mobility within one year after a periprosthetic hip fracture.
- Mortality is substantially lower than that after a proximal femoral fracture.
-
Question 5
Which Vancouver classification type corresponds to a periprosthetic hip fracture distal to the stem?- Type A;
- Type B1;
- Type B2;
- Type B3;
- Type C
-
Question 6
According to the article, which statement regarding nonoperative treatment of periprosthetic fractures is correct?- It is the treatment of choice for all displaced fractures.
- It should involve prolonged immobilization to improve fracture healing.
- It should be considered only for nondisplaced fractures with a stable implant component or in patients at prohibitive surgical risk.
- It is generally superior to surgical revision in the presence of a loose implant component.
- It does not require follow-up radiographs.
-
Question 7
Which recommendation regarding secondary prevention following a periprosthetic fracture is explicitly stated in the article?- Vitamin D supplementation is generally contraindicated.
- After a periprosthetic fracture, an osteoporosis evaluation is generally not required.
- Secondary prevention is limited to a strict prohibition on sports.
- Osteoporosis evaluation should be initiated with a low threshold in patients with risk factors.
- No further preventive measures are required after fracture healing.
-
Question 8
Which operation is generally indicated for a Vancouver B3 periprosthetic femoral fracture with inadequate proximal bone stock?- stem revision using a long-stem revision prosthesis, possibly supplemented by bone augmentation or proximal femoral replacement
- nonoperative treatment with partial weight-bearing and follow-up radiographs
- isolated locking plate fixation with cerclage wires while retaining the stem
- debridement, antibiotics, and analgesics only
- primary hip fusion while retaining the stem and applying cerclage wires
-
Question 9
According to the article, which statement regarding preoperative joint aspiration in cases of suspected periprosthetic infection is correct?- It is unnecessary if the radiograph already shows a fracture.
- It is part of the extended diagnostic workup for infection and should be performed before any antibiotic therapy is initiated.
- It should be performed only after empirical antibiotic therapy has been initiated.
- It is useful only for shoulder and knee prostheses, and then only in patients with severe pain.
- Its sole purpose is to relieve pain by reducing pressure, not to aid diagnostics.
-
Question 10
Which postoperative treatment strategy is generally pursued after surgery for periprosthetic fractures?- strict bed rest for several weeks to ensure fracture healing
- long-term non-weight-bearing on the operated limb, regardless of the fixation procedure
- immobilization in a plaster cast until radiographic confirmation of bony union
- fixation that allows full weight-bearing whenever possible, with early functional mobilization
- progressive weight-bearing starting no earlier than six weeks after surgery, regardless of fracture type and surgical treatment
References (abbreviated)
- 1.Endoprothesenregister Deutschland (EPRD): Jahresbericht. 2025. www.eprd.de/de/downloads-1/berichte
- 2. Meek RMD, et al. J Bone Joint Surg Br. 2011;93:96–101. doi: 10.1302/0301-620X.93B1.25087. [DOI] [PubMed] [Google Scholar]
- 3. Bhattacharyya T, et al. J Bone Joint Surg Am. 2007;89:2658–62. doi: 10.2106/JBJS.F.01538. [DOI] [PubMed] [Google Scholar]
- 4. Lamb JN, et al. J Arthroplasty. 2022;37:398-405.e1. doi: 10.1016/j.arth.2021.09.006. [DOI] [PubMed] [Google Scholar]
- 5. Thien TM, et al. J Bone Joint Surg Am. 2014;96:e167. doi: 10.2106/JBJS.M.00643. [DOI] [PubMed] [Google Scholar]
- 6. Sidler-Maier CC, Waddell JP. Int Orthop. 2015;39:1673–82. doi: 10.1007/s00264-015-2721-y. [DOI] [PubMed] [Google Scholar]
- 7. Risager SK, et al. J Arthroplasty. 2024;39:2615–20. doi: 10.1016/j.arth.2024.05.033. [DOI] [PubMed] [Google Scholar]
- 8. Frosch KH, Madert J. OP-Journal. 2015;31:37–44. [Google Scholar]
- 9. Lindahl H, et al. J Arthroplasty. 2005;20:857–65. doi: 10.1016/j.arth.2005.02.001. [DOI] [PubMed] [Google Scholar]
- 10. Ruchholtz S, et al. Eur Orthop Traumatol. 2013;4:93–102. doi: 10.1007/s12570-012-0130-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Abdel MP, et al. Bone Joint J. 2016;98-B:461–7. doi: 10.1302/0301-620X.98B4.37201. [DOI] [PubMed] [Google Scholar]
- 12. Zhao WQ, et al. Ann Med. 2025;57:2494679. doi: 10.1080/07853890.2025.2494679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Houel V, et al. Osteoporos Int. 2025;36:1061–8. doi: 10.1007/s00198-025-07486-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. COMPOSE Study Team. Bone Joint J. 2022;104-B:997–1008. doi: 10.1302/0301-620X.104B8.BJJ-2021-1682.R1. [DOI] [PubMed] [Google Scholar]
- 15. Streubel PN, et al. Clin Orthop Relat Res. 2011;469:1188–96. doi: 10.1007/s11999-010-1530-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Stanley R, et al. J Orthop Surg Res. 2025;20:967. doi: 10.1186/s13018-025-06446-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Masri BA, et al. Clin Orthop Relat Res. 2004;420:80–95. doi: 10.1097/00003086-200403000-00012. [DOI] [PubMed] [Google Scholar]
- 18. Stoffel K, et al. EFORT Open Rev. 2020;5:449–56. doi: 10.1302/2058-5241.5.190086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Bauer J, et al. Curr Osteoporos Rep. 2025;23:29. doi: 10.1007/s11914-025-00922-5. [DOI] [PubMed] [Google Scholar]
- 20. Lindberg-Larsen M, et al. Acta Orthop. 2017;88:390–4. doi: 10.1080/17453674.2017.1302908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Gruner A, et al. Unfallchirurg. 2004;107:35–49. doi: 10.1007/s00113-003-0698-2. [DOI] [PubMed] [Google Scholar]
- 22. Ramavath A, et al. EFORT Open Rev. 2020;5:558–67. doi: 10.1302/2058-5241.5.200003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Parvizi J, et al. J Arthroplasty. 2018;33:1309–14. doi: 10.1016/j.arth.2018.02.078. [DOI] [PubMed] [Google Scholar]
- 24. Duncan CP, et al. Instr Course Lect. 1995;44:293–304. [PubMed] [Google Scholar]
- 25. Rorabeck CH, Taylor JW. Orthop Clin North Am. 1999;30:209–14. doi: 10.1016/s0030-5898(05)70075-4. [DOI] [PubMed] [Google Scholar]
- 26. Felix NA, et al. Clin Orthop Relat Res. 1997;345:113–24. [PubMed] [Google Scholar]
- 27. Ortiguera CJ, Berry DJ. J Bone Joint Surg Am. 2002;84:532–40. doi: 10.2106/00004623-200204000-00004. [DOI] [PubMed] [Google Scholar]
- 28. Pascarella R, et al. Injury. 2018;49(Suppl 3):S65–S73. doi: 10.1016/j.injury.2018.09.061. [DOI] [PubMed] [Google Scholar]
- 29. Duncan CP, Haddad FS. Bone Joint J. 2014;96-B:713–6. doi: 10.1302/0301-620X.96B6.34040. [DOI] [PubMed] [Google Scholar]
- 30. Peterson CA, Lewallen DG. J Bone Joint Surg Am. 1996;78:1206–13. doi: 10.2106/00004623-199608000-00011. [DOI] [PubMed] [Google Scholar]
- 31. Su ET, et al. J Am Acad Orthop Surg. 2004;12:12–20. doi: 10.5435/00124635-200401000-00003. [DOI] [PubMed] [Google Scholar]
- 32. Keating EM, et al. Clin Orthop Relat Res. 2003;416:93–7. doi: 10.1097/01.blo.0000092992.90435.20. [DOI] [PubMed] [Google Scholar]
- 33. Choudhary Z, et al. JBJS Rev. 2025;13:12. doi: 10.2106/JBJS.RVW.25.00215. [DOI] [PubMed] [Google Scholar]
- 34. Maggs JL, et al. Bone Joint J. 2021;103-B:71–8. doi: 10.1302/0301-620X.103B1.BJJ-2020-0163.R1. [DOI] [PubMed] [Google Scholar]
- 35. Aprato A, et al. J Orthop Traumatol. 2020;21:12. doi: 10.1186/s10195-020-00550-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Dachverband Osteologie e.V. (DVO): Stuttgart: Dachverband Osteologie. 2023.
